Prognostic factors after multimodality treatment for pleural mesothelioma
Interdisciplinary CardioVascular and Thoracic Surgery · 02.11.2026
DOI: 10.1093/icvts/ivag296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 02.11.2026. Verfasst von Masaki Hashimoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Hyogo Medical University, Nishinomiya, Japan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To investigate prognostic factors associated with overall survival (OS) in patients with pleural mesothelioma (PM) undergoing curative-intent surgery as part of multimodality treatment (MMT).
Methods
This retrospective two-centre cohort included 255 patients treated between 2006 and 2019. OS was measured from the date of histological diagnosis and analyzed using Cox proportional hazards regression as the primary analysis. A secondary logistic regression analysis evaluated 5-year survival among patients with ascertainable 5-year vital status. A sensitivity Cox analysis used the date of surgery as the time origin.
Results
Among 255 patients, 77 (30.2%) survived ≥5 years after diagnosis. All 255 patients and 192 deaths were included in the primary Cox analysis. Age ≥70 years (HR 1.49, 95% CI 1.04–2.14; P=.029), non-epithelioid histology (HR 2.22, 95% CI 1.33–3.72; P=.002), preoperative T2–4 disease according to the 9th edition TNM classification (HR 2.47, 95% CI 1.78–3.43; P<.001), severe postoperative complications (HR 2.62, 95% CI 1.85–3.70; P<.001), and blood loss >1465 mL (HR 1.39, 95% CI 1.03–1.87; P=.030) were independently associated with poorer OS. Fifteen patients alive at last contact but censored before 5 years were excluded from the secondary 5-year analysis, leaving 240 patients (77 surviving ≥5 years and 163 dying before 5 years). Results were materially unchanged when OS was measured from surgery.
Conclusions
Advanced age, non-epithelioid histology, higher preoperative T category according to the 9th edition TNM classification, severe postoperative complications, and greater intraoperative blood loss were independently associated with poorer OS in this highly selected surgically treated cohort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Hyogo Medical University, Nishinomiya, Japan.
- Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Japan.
Zitieren
APA
Hashimoto, M., Nakamura, S., Nakamura, A., Nakamichi, T., Kuroda, A., Takegahara, K., Kato, T., Fukumoto, K., Matsumoto, S., Kondo, N., Chen-Yoshikawa, T. F., Hasegawa, S., & Funaki, S. (2026). Prognostic factors after multimodality treatment for pleural mesothelioma. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivag296
Vancouver
Hashimoto M, Nakamura S, Nakamura A, Nakamichi T, Kuroda A, Takegahara K, et al. Prognostic factors after multimodality treatment for pleural mesothelioma. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivag296
BibTeX
@article{Hashimoto2026,
author = {Hashimoto, Masaki and Nakamura, Shota and Nakamura, Akifumi and Nakamichi, Toru and Kuroda, Ayumi and Takegahara, Kyoshiro and Kato, Taketo and Fukumoto, Koichi and Matsumoto, Seiji and Kondo, Nobuyuki and Chen-Yoshikawa, Toyofumi Fengshi and Hasegawa, Seiki and Funaki, Soichiro},
title = {Prognostic factors after multimodality treatment for pleural mesothelioma},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
doi = {10.1093/icvts/ivag296}
}
EUVIMED